If you are like me, you find it difficult to devote an entire hour, even if the topic is of great interest. This video is a short “Mini-webinar” that will take under 15 minutes to watch. – John J. S. Cadwell, CEO

SUMMARY: The Hollow Fiber Infection Model (HFIM) can precisely mimic the time course of human antibiotic bioavailability and measure efficacy, optimize dosage profiles, and reveal emerging resistance. It can also be used to study anti-viral compounds.  This mini-webinar describes the set-up of the HFIM in any laboratory, and gives examples of its use. The HFIM is endorsed by the EMA as a validated method for submitting drug data to the agency.